Methods: Both cost-utility
analysis and cost-benefit analysis were applied to models that allow
for population movement across regions with different characteristics
of tuberculosis burden, transmission, and access to treatment. Costbenefit
data were drawn primarily from estimates published by the
World Health Organization, and disease transmission data were
drawn from a previously published model.